E2F1 proteolysis via SCF ‐cyclin F underlies synthetic lethality between cyclin F loss and Chk1 inhibition
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
E2F1 proteolysis via
SCF
‐cyclin F underlies synthetic lethality between cyclin F loss and Chk1 inhibition
Authors
Keywords
-
Journal
EMBO JOURNAL
Volume -, Issue -, Pages -
Publisher
EMBO
Online
2019-08-19
DOI
10.15252/embj.2018101443
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cyclin F Controls Cell-Cycle Transcriptional Outputs by Directing the Degradation of the Three Activator E2Fs
- (2019) Linda Clijsters et al. MOLECULAR CELL
- DNA Replication Determines Timing of Mitosis by Restricting CDK1 and PLK1 Activation
- (2018) Bennie Lemmens et al. MOLECULAR CELL
- Mechanisms of Oncogene-Induced Replication Stress: Jigsaw Falling into Place
- (2018) Panagiotis Kotsantis et al. Cancer Discovery
- Targeting the Vulnerability of RB Tumor Suppressor Loss in Triple-Negative Breast Cancer
- (2018) Agnieszka K. Witkiewicz et al. Cell Reports
- Intragenic origins due to short G1 phases underlie oncogene-induced DNA replication stress
- (2018) Morgane Macheret et al. NATURE
- β-TrCP- and Casein Kinase II-Mediated Degradation of Cyclin F Controls Timely Mitotic Progression
- (2018) Ioanna Mavrommati et al. Cell Reports
- Transcription shapes DNA replication initiation and termination in human cells
- (2018) Yu-Hung Chen et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Applications of chemogenomic library screening in drug discovery
- (2017) Lyn H. Jones et al. NATURE REVIEWS DRUG DISCOVERY
- Progress towards a public chemogenomic set for protein kinases and a call for contributions
- (2017) David H. Drewry et al. PLoS One
- RB1: a prototype tumor suppressor and an enigma
- (2016) Nicholas J. Dyson GENES & DEVELOPMENT
- Distinct but Concerted Roles of ATR, DNA-PK, and Chk1 in Countering Replication Stress during S Phase
- (2015) Rémi Buisson et al. MOLECULAR CELL
- Comprehensive characterization of the Published Kinase Inhibitor Set
- (2015) Jonathan M Elkins et al. NATURE BIOTECHNOLOGY
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- Cyclin F suppresses B-Myb activity to promote cell cycle checkpoint control
- (2015) Ditte Kjærsgaard Klein et al. Nature Communications
- The Molecular Signatures Database Hallmark Gene Set Collection
- (2015) Arthur Liberzon et al. Cell Systems
- DNA Replication and Oncogene-Induced Replicative Stress
- (2014) Stephanie A. Hills et al. CURRENT BIOLOGY
- GSVA: gene set variation analysis for microarray and RNA-Seq data
- (2013) Sonja Hänzelmann et al. BMC BIOINFORMATICS
- ATR Prohibits Replication Catastrophe by Preventing Global Exhaustion of RPA
- (2013) Luis Ignacio Toledo et al. CELL
- Cdks, cyclins and CKIs: roles beyond cell cycle regulation
- (2013) S. Lim et al. DEVELOPMENT
- Characterization and preclinical development of LY2603618: a selective and potent Chk1 inhibitor
- (2013) Constance King et al. INVESTIGATIONAL NEW DRUGS
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Cyclin F-Mediated Degradation of Ribonucleotide Reductase M2 Controls Genome Integrity and DNA Repair
- (2012) Vincenzo D'Angiolella et al. CELL
- Regulation of E2F1 by APC/CCdh1via K11 linkage-specific ubiquitin chain formation
- (2012) Varija Budhavarapu et al. CELL CYCLE
- CCT244747 Is a Novel Potent and Selective CHK1 Inhibitor with Oral Efficacy Alone and in Combination with Genotoxic Anticancer Drugs
- (2012) M. I. Walton et al. CLINICAL CANCER RESEARCH
- A cyclin without cyclin-dependent kinases: cyclin F controls genome stability through ubiquitin-mediated proteolysis
- (2012) Vincenzo D’Angiolella et al. TRENDS IN CELL BIOLOGY
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Discovery of Potent and Selective Inhibitors of Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase as Potential Anticancer Agents
- (2011) Jean-Damien Charrier et al. JOURNAL OF MEDICINAL CHEMISTRY
- SCFCyclin F controls centrosome homeostasis and mitotic fidelity through CP110 degradation
- (2010) Vincenzo D’Angiolella et al. NATURE
- An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
- (2009) Teresa A. Soucy et al. NATURE
- Breaching the DNA damage checkpoint via PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1
- (2008) A. Blasina et al. MOLECULAR CANCER THERAPEUTICS
- AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies
- (2008) S. D. Zabludoff et al. MOLECULAR CANCER THERAPEUTICS
- PID: the Pathway Interaction Database
- (2008) Carl F. Schaefer et al. NUCLEIC ACIDS RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now